Literature DB >> 23940456

Ischemic postconditioning decreases matrix metalloproteinase-2 expression during ischemia-reperfusion of myocardium in a rabbit model: A preliminary report.

Zhong-Zhi Liu1, Jing-Bo Kong, Feng-Zhi Li, Long-Le Ma, Shu-Qin Liu, Le-Xin Wang.   

Abstract

OBJECTIVE: To investigate the effect of ischemic postconditioning on the expression of matrix metalloproteinase (MMP)-2 during ischemia-reperfusion of myocardium in a rabbit model.
METHODS: Thirty-six male New Zealand white rabbits were randomly divided into sham, ischemia-reperfusion and ischemic postconditioning groups. Myocardial ischemia-reperfusion was created by ligating the left anterior descending coronary artery for 30 min followed by 3 h of reperfusion. Myocardial infarction sizes were determined by dual staining with triphenyltetrazolium chloride and trypan blue. Plasma levels of MMP-2 were measured using ELISA. Myocardial MMP-2 messenger RNA was analyzed by reverse transcription polymerase chain reaction.
RESULTS: The mean (± SD) infarct size in the ischemic postconditioning group was significantly smaller compared with the ischemia-reperfusion group (37.1±3.8% versus 57.5±1.9%; P=0.02). The incidence of ventricular tachycardia in the ischemic postconditioning group was also lower than in the ischemia-reperfusion group (8.5% versus 75%; P=0.003). MMP-2 messenger RNA expression in the ischemic postconditioning group was significantly lower compared with the ischemia-reperfusion group (0.4944±0.0476 versus 0.6989±0.0694; P=0.02).
CONCLUSION: Ischemic postconditioning reduces myocardial ischemia-reperfusion injury, possibly by inhibiting the expression of MMP-2.

Entities:  

Keywords:  Acute myocardial infarction; Ischemia-reperfusion; Ischemic postconditioning; Matrix metalloproteinase-2; Rabbits

Year:  2013        PMID: 23940456      PMCID: PMC3718608     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  18 in total

1.  Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury.

Authors:  Wenjie Wang; Costas J Schulze; Wilma L Suarez-Pinzon; Jason R B Dyck; Grzegorz Sawicki; Richard Schulz
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

Review 2.  2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven R Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan M Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; Eric D Peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

3.  Ischemic postconditioning promotes left ventricular functional recovery after cardioplegic arrest in an in vivo piglet model of global ischemia reperfusion injury on cardiopulmonary bypass.

Authors:  Gen Shinohara; Kiyozo Morita; Ryuichi Nagahori; Yoshihiro Koh; Katsushi Kinouchi; Takayuki Abe; Kazuhiro Hashimoto
Journal:  J Thorac Cardiovasc Surg       Date:  2011-02-25       Impact factor: 5.209

4.  Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.

Authors:  Lennart Nilsson; Jonas Hallén; Dan Atar; Lena Jonasson; Eva Swahn
Journal:  Heart       Date:  2011-07-04       Impact factor: 5.994

5.  Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.

Authors:  Wenjie Wang; Grzegorz Sawicki; Richard Schulz
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

6.  Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.

Authors:  Zoltán Giricz; Manoj M Lalu; Csaba Csonka; Péter Bencsik; Richard Schulz; Péter Ferdinandy
Journal:  J Pharmacol Exp Ther       Date:  2005-09-15       Impact factor: 4.030

7.  Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species.

Authors:  Maria-Giulia Perrelli; Pasquale Pagliaro; Claudia Penna
Journal:  World J Cardiol       Date:  2011-06-26

8.  Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.

Authors:  P Y Cheung; G Sawicki; M Wozniak; W Wang; M W Radomski; R Schulz
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

9.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

Authors:  Zhi-Qing Zhao; Joel S Corvera; Michael E Halkos; Faraz Kerendi; Ning-Ping Wang; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

10.  Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning.

Authors:  Martín Donato; Verónica D'Annunzio; Bruno Buchholz; Verónica Miksztowicz; Cristina Lorenzo Carrión; Laura B Valdez; Tamara Zaobornyj; Laura Schreier; Regina Wikinski; Alberto Boveris; Gabriela Berg; Ricardo J Gelpi
Journal:  Exp Physiol       Date:  2009-10-30       Impact factor: 2.969

View more
  2 in total

1.  Ischemic postconditioning improves the expression of cellular membrane connexin 43 and attenuates the reperfusion injury in rat acute myocardial infarction.

Authors:  Hua He; Nan Li; Zhihong Zhao; Fusheng Han; Xifu Wang; Yujie Zeng
Journal:  Biomed Rep       Date:  2015-06-30

2.  Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-α serine/threonine-protein kinase and nuclear factor-κB signaling pathways.

Authors:  Lixin Wang; Hao Ma; Yan Xue; Haiyan Shi; Teng Ma; Xiaozheng Cui
Journal:  Exp Ther Med       Date:  2017-11-27       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.